IFN-γ and TNF-α producers in the blood from the NSCLC patients represented approximately 10% of the CD8+ Teff cells, which was significantly lower compared to the levels observed in the blood from the healthy donors (p = 0.0061) (p = 0.0001) (Fig. 4a, b). This evidence concerns the gene TNF and non-small cell lung carcinoma.